Practical Geriatrics ›› 2024, Vol. 38 ›› Issue (9): 948-952.doi: 10.3969/j.issn.1003-9198.2024.09.020
Previous Articles Next Articles
Received:2023-11-26
Online:2024-09-20
Published:2024-10-23
CLC Number:
| [1] 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会. 成人阻塞性睡眠呼吸暂停基层诊疗指南(2018年)[J]. 中华全科医师杂志, 2019,18(1):21-29. [2] KUO C Y, HSIAO H T, LO I H, et al. Association between obstructive sleep apnea, its treatment, and Alzheimer’s disease: systematic mini-review[J]. Front Aging Neurosci, 2021,12:591737. [3] 中华医学会神经病学分会痴呆与认知障碍学组. 阿尔茨海默病源性轻度认知障碍诊疗中国专家共识2021[J]. 中华神经科杂志, 2022,55(5):421-440. [4] JONGSIRIYANYONG S, LIMPAWATTANA P. Mild cognitive impairment in clinical practice: a review article[J]. Am J Alzheimers Dis Other Demen, 2018,33(8):500-507. [5] CIPRIANI G, LUCETTI C, DANTI S, et al. Sleep disturbances and dementia[J]. Psychogeriatrics, 2014,15(1):65-74. [6] CHENG J X, REN J, QIU J, et al. Rapid eye movement sleep and slow wave sleep rebounded and related factors during positive airway pressure therapy[J]. Sci Rep, 2021,11(1):7599. [7] CARNICELLI L, MAESTRI M, DI COSCIO E, et al. A longitudinal study of polysomnographic variables in patients with mild cognitive impairment converting to Alzheimer’s disease[J]. J Sleep Res, 2019,28(5):e12821. [8] TADOKORO K, OHTA Y, HISHIKAWA N, et al. Discrepancy of subjective and objective sleep problems in Alzheimer’s disease and mild cognitive impairment detected by a home-based sleep analysis[J]. J Clin Neurosci, 2020,74:76-80. [9] CHOE Y M, SUH G H, KIM J W. Association of a history of sleep disorder with risk of mild cognitive impairment and Alzheimer’s disease dementia[J]. Psychiatry Investig, 2022,19(10):840-846. [10] TSAI M S, LI H Y, HUANG C G, et al. Risk of Alzheimer’s disease in obstructive sleep apnea patients with or without treatment: real-world evidence[J]. Laryngoscope, 2020,130(9):2292-2298. [11] AINI N, CHU H, BANDA K J, et al. Prevalence of sleep-related breathing disorders and associated risk factors among people with dementia: a meta-analysis[J]. Sleep Med, 2023,103:51-61. [12] GAETA A M, BENÍTEZ I D, JORGE C, et al. Prevalence of obstructive sleep apnea in Alzheimer’s disease patients[J]. J Neurol, 2019,267(4):1012-1022. [13] FERNANDES M, MARI L, CHIARAVALLOTI A, et al. 18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment[J]. J Neurol, 2022,269(10):5356-5367. [14] VANEK J, PRASKO J, GENZOR S, et al. Obstructive sleep apnea, depression and cognitive impairment[J]. Sleep Med, 2020,72:50-58. [15] KRISHNAN S, CHAI-COETZER C L, GRIVELL N, et al. Comorbidities and quality of life in australian men and women with diagnosed and undiagnosed high-risk obstructive sleep apnea[J]. J Clin Sleep Med, 2022,18(7):1757-1767. [16] GRANDNER M A, MIN J S, SAAD R, et al. Health-related impact of illness associated with excessive daytime sleepiness in patients with obstructive sleep apnea[J]. Postgrad Med, 2023,135(5):501-510. [17] CHOU K T, TSAI Y L, YEH W Y, et al. Risk of work-related injury in workers with obstructive sleep apnea: a systematic review and meta-analysis[J]. J Sleep Res, 2021,31(1):e13446. [18] 汤韫钰, 刘如恩. 阿尔兹海默病的诊断与综合治疗进展[J]. 中国实用神经疾病杂志, 2022,25(8):996-1000. [19] MARTINEAU-DUSSAULT M È, ANDRÉ C, DANEAULT V, et al. Medial temporal lobe and obstructive sleep apnea: effect of sex, age, cognitive status and free-water[J]. Neuroimage Clin, 2022,36:103235. [20] ZHOU L, LIU G, LUO H, et al. Aberrant hippocampal network connectivity is associated with neurocognitive dysfunction in patients with moderate and severe obstructive sleep apnea[J]. Front Neurol, 2020,11:580408 [21] BUBU O M, PIRRAGLIA E, ANDRADE A G, et al. Obstructive sleep apnea and longitudinal Alzheimer’s disease biomarker changes[J]. Sleep, 2019,42(6):zsz048. [22] LIGUORI C, MERCURI N B, NUCCETELLI M, et al. Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer’s disease risk?[J]. Sleep Med, 2019,56:171-176. [23] DAKTERZADA F, BENÍTEZ I D, TARGA A, et al. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease[J]. Alzheimers Res Ther, 2023,15(1):134. [24] OWEN J E, BENEDIKTSDOTTIR B, COOK E, et al. Alzheimer’s disease neuropathology in the hippocampus and brainstem of people with obstructive sleep apnea[J]. Sleep, 2021,44(3):zsaa195. [25] KAZIM S F, SHARMA A, SAROJA S R, et al. Chronic intermittent hypoxia enhances pathological tau seeding, propagation, and accumulation and exacerbates Alzheimer-like memory and synaptic plasticity deficits and molecular signatures[J]. Biol Psychiatry, 2022,91(4):346-358. [26] WANG H, XIONG W, HANG S, et al. Depletion of SENP1-mediated PPARγ SUMOylation exaggerates intermittent hypoxia-induced cognitive decline by aggravating microglia-mediated neuroinflammation[J]. Aging: Albany NY, 2021,13(11):15240-15254. [27] WU X, GONG L, XIE L, et al. NLRP3 deficiency protects against intermittent hypoxia-induced neuroinflammation and mitochondrial ROS by promoting the PINK1-Parkin pathway of mitophagy in a murine model of sleep apnea[J]. Front Immunol, 2021,12:628168. [28] HUMPHREY C M, HOOKER J W, THAPA M, et al. Synaptic loss and gliosis in the nucleus tractus solitarii with streptozotocin-induced Alzheimer’s disease[J]. Brain Res, 2023,1801:148202. [29] ALEXANDER C, LI T, HATTORI Y, et al. Hypoxia inducible factor-1α binds and activates γ-secretase for Aβ production under hypoxia and cerebral hypoperfusion[J]. Mol Psychiatry, 2022,27(10):4264-4273. [30] QIAN L, RAWASHDEH O, KASAS L, et al. Cholinergic basal forebrain degeneration due to sleep-disordered breathing exacerbates pathology in a mouse model of Alzheimer’s disease[J]. Nat Commun, 2022,13(1):6543. [31] ROMIGI A, PRZYBYLSKA-KUĆ S, ZAKRZEWSKI M, et al. Obstructive sleep apnea may increase the risk of Alzheimer’s disease[J]. PLoS One, 2019,14(9):e0221255. [32] LEI L, FENG J, WU G, et al. HIF-1α causes LCMT1/PP2A deficiency and mediates tau hyperphosphorylation and cognitive dysfunction during chronic hypoxia[J]. Int J Mol Sci, 2022,23(24):16140. [33] BARIL A A, CARRIER J, LAFRENIÈRE A, et al. Biomarkers of dementia in obstructive sleep apnea[J]. Sleep Med Rev, 2018,42:139-148. [34] MACHEDA T, ROBERTS K, LYONS D N, et al. Chronic intermittent hypoxia induces robust astrogliosis in an Alzheimer’s disease-relevant mouse model[J]. Neuroscience, 2019,398:55-63. [35] SAPIN E, PEYRON C, ROCHE F, et al. Chronic intermittent hypoxia induces chronic low-grade neuroinflammation in the dorsal hippocampus of mice[J]. Sleep, 2015,38(10):1537-1546. [36] WANG H, YANG T, SUN J, et al. SENP1 modulates microglia-mediated neuroinflammation toward intermittent hypoxia-induced cognitive decline through the de-SUMOylation of NEMO[J]. J Cell Mol Med, 2021,25(14):6841-6854. [37] KHUU M A, PAGAN C M, NALLAMOTHU T, et al. Intermittent hypoxia disrupts adult neurogenesis and synaptic plasticity in the dentate gyrus[J]. J Neurosci, 2019,39(7):1320-1331. [38] CARNEY R S E DPHIL. Neurocognitive and synaptic potentiation deficits are mitigated by inhibition of HIF1a signaling following intermittent hypoxia in rodents[J]. eNeuro, 2020,7(6):ENEURO. 0449-20.2020. [39] ARIAS-CAVIERES A, FONTEH A, CASTRO-RIVERA C I, et al. Intermittent hypoxia causes targeted disruption to NMDA receptor dependent synaptic plasticity in area CA1 of the hippocampus[J]. Exp Neurol, 2021,344:113808. [40] KHUU M A, NALLAMOTHU T, CASTRO-RIVERA C I, et al. Stage-dependent effects of intermittent hypoxia influence the outcome of hippocampal adult neurogenesis[J]. Sci Rep, 2021,11(1):6005. |
| [1] | . [J]. Practical Geriatrics, 2024, 38(8): 770-774. |
| [2] | . [J]. Practical Geriatrics, 2024, 38(8): 857-861. |
| [3] | LI Qingyang, WANG Chanjuan, WANG Zheng. Study on the correlation of cognitive function with swallowing function and nutritional status in the elderly patients with Alzheimer’s disease [J]. Practical Geriatrics, 2024, 38(6): 577-581. |
| [4] | . [J]. Practical Geriatrics, 2024, 38(6): 634-638. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
